Wikipedia's English Clinical Research Glossary
Jump to navigation
Jump to search
A Wikipedia's English Clinical Research Glossary is a English clinical research glossary that is a Wikipedia-based glossary.
- Example(s):
- Counter-Example(s):
- See: Clinical Research Terminology.
References
2021
- (Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Glossary_of_clinical_research Retrieved:2021-11-6.
- A glossary of terms used in clinical research.
A
- Activities of daily living
- Adverse drug reaction
- Adverse effect
- Adverse event
- Adverse reaction
- Advocacy and support groups
- Animal model
- Animal study
- Applicable regulatory requirement
- Approval
- Approved drugs
- Arm
- Audit certificate
- Audit report
- Audit trail
- Audit
B
- Baseline
- Bayesian approaches
- Best practice
- Bias
- Bioavailable
- Bioinformatics
- Biological drug
- Biometrics
- Biometry
- Biostatistics
- Blind
- Blind Review
- Blinded study
C
- Case report
- Case report form
- Case series
- Case-control study
- Clinical
- Clinical endpoint
- Clinical investigation
- Clinical investigator
- Clinical practice guidelines
- Clinical researcher
- Clinical series
- Clinical study or Clinical trial
- Clinical trial protocol
- Cohort (statistics)
- Cohort study
- Community-based clinical trial (CBCT)
- Comparator
- Compassionate use
- Compassionate use trial
- Complementary and alternative therapy
- Compliance
- Confidentiality regarding trial participants
- Consecutive case series
- Content validity
- Contract Research Organization
- Contract
- Contraindication
- Control
- Control animal
- Control group
- Controlled clinical trial
- Controlled trials
- Coordinating Committee
- Coordinating Investigator
D
- Data and Safety Monitoring Board or Independent Data Monitoring Committee
- Diagnostic trials
- Direct Access
- Documentation
- Dose
- Dose-dependent
- Dose-limiting
- Dose-ranging study
- Dose-rate
- Double-blind study
- Double-dummy
- Dropout
- Drug
- Drug-drug interaction
E
- Efficacy
- Eligibility criteria
- Empirical
- Endpoint
- Enrolling
- Epidemiology
- Equivalence trial
- Essential Documents
- Evaluable disease
- Evaluable patients
- Expanded access
- Expanded access trial
- Experimental
- Experimental drug
F
G
H
I
- Impartial Witness
- In vitro
- In vivo
- Incidence
- Inclusion/exclusion criteria
- Independent Ethics Committee
- Indication
- Informed consent
- Informed consent document
- Inspection
- Institution
- Institutional Review Board (IRB)
- Intent to treat
- Interaction
- Inter-rater reliability
- Interim analysis
- Interim Clinical Trial/Study Report
- Intervention
- Intervention group
- Intervention name
- Intra-rater reliability
- Investigational
- Investigational drug
- Investigational New Drug
- Investigator
- Investigator's Brochure
L
M
N
- NCI
- National Institutes of Health
- Natural history study
- New Drug Application (NDA)
- Nonconsecutive case series
O
- Observation
- Observational study
- Off-label
- Open label study
- Orphan drugs
- Outpatient
- Over-the-counter drug
P
- Patient advocate
- Peer review
- Pharmacokinetics
- Phase I clinical trials
- Phase II clinical trials
- Phase III clinical trials
- Phase IV clinical trial
- Clinical
- Pilot study
- Placebo effect
- Placebo controlled study
- Placebo
- Population study
- Preclinical
- Prevention
- Prospective cohort study
Q
- Quality Assurance
- Quality of life trials (or supportive care trials)
R
- Randomization
- Randomized clinical trial
- Recruiting
- Regimen
- Retrospective cohort study
- Retrospective
- Risk-benefit ratio
S
- Control
- Selection bias
- Single blind study
- Sponsor
- Standard Operating Procedures
- Standard treatment
- Standards of care
- Statistical significance
- Significant
- Study endpoint
T
U
- NLM
- Uncontrolled study
- Unexpected Adverse Drug Reaction
V
- Vulnerable Subjects
W
- Well-being of the trial subjects